91 related articles for article (PubMed ID: 20141446)
1. Am80 inhibits stromal cell-derived factor-1-induced chemotaxis in T-cell acute lymphoblastic leukemia cells.
Matsumoto T; Jimi S; Hara S; Takamatsu Y; Suzumiya J; Tamura K
Leuk Lymphoma; 2010 Mar; 51(3):507-14. PubMed ID: 20141446
[TBL] [Abstract][Full Text] [Related]
2. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.
Crazzolara R; Kreczy A; Mann G; Heitger A; Eibl G; Fink FM; Möhle R; Meister B
Br J Haematol; 2001 Dec; 115(3):545-53. PubMed ID: 11736934
[TBL] [Abstract][Full Text] [Related]
3. TCR activation inhibits chemotaxis toward stromal cell-derived factor-1: evidence for reciprocal regulation between CXCR4 and the TCR.
Peacock JW; Jirik FR
J Immunol; 1999 Jan; 162(1):215-23. PubMed ID: 9886389
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
5. [Level of SDF-1/CXCR4 in children with acute leukemia and its significance].
Wen Q; Chen RL; Cai KR; Lin YW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):324-6. PubMed ID: 21518481
[TBL] [Abstract][Full Text] [Related]
6. Bryostatin-5 blocks stromal cell-derived factor-1 induced chemotaxis via desensitization and down-regulation of cell surface CXCR4 receptors.
He X; Fang L; Wang J; Yi Y; Zhang S; Xie X
Cancer Res; 2008 Nov; 68(21):8678-86. PubMed ID: 18974109
[TBL] [Abstract][Full Text] [Related]
7. HIV-1-Tat potentiates CXCL12/stromal cell-derived factor 1-induced downregulation of membrane CXCR4 in T lymphocytes through protein kinase C zeta.
Hidalgo-Estévez AM; Punzón C; Sanchez-Duffhues G; Muñoz E; Fresno M
Mol Immunol; 2008 Nov; 46(1):106-15. PubMed ID: 18760839
[TBL] [Abstract][Full Text] [Related]
8. [Expression of SDF-1alpha and its receptor CXCR4 in acute leukemias and their relationship with extramedullary infiltration].
Liu ZR; Sun H; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):1-5. PubMed ID: 16584580
[TBL] [Abstract][Full Text] [Related]
9. [The expression and clinical significance of stromal cell-derived factor-1 and CXCR4 in acute leukemia and malignant lymphoma].
Zeng DF; Kong PY; Chen XH; Wei L; Chang C; Peng XG
Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):522-4. PubMed ID: 16080846
[TBL] [Abstract][Full Text] [Related]
10. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies.
Peled A; Klein S; Beider K; Burger JA; Abraham M
Cytokine; 2018 Sep; 109():11-16. PubMed ID: 29903571
[TBL] [Abstract][Full Text] [Related]
11. Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4/CXCL12 axis.
de Rooij B; Polak R; van den Berk LCJ; Stalpers F; Pieters R; den Boer ML
Haematologica; 2017 Oct; 102(10):e389-e393. PubMed ID: 28619846
[No Abstract] [Full Text] [Related]
12. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity.
Tan Y; Du J; Cai S; Li X; Ma W; Guo Z; Chen H; Huang Z; Xiao J; Cai L; Cai S
Exp Hematol; 2006 Nov; 34(11):1553-62. PubMed ID: 17046575
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
[TBL] [Abstract][Full Text] [Related]
14. Identification of hepatic niche harboring human acute lymphoblastic leukemic cells via the SDF-1/CXCR4 axis.
Kato I; Niwa A; Heike T; Fujino H; Saito MK; Umeda K; Hiramatsu H; Ito M; Morita M; Nishinaka Y; Adachi S; Ishikawa F; Nakahata T
PLoS One; 2011; 6(11):e27042. PubMed ID: 22069486
[TBL] [Abstract][Full Text] [Related]
15. Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML.
Sison EA; McIntyre E; Magoon D; Brown P
Mol Cancer Res; 2013 Sep; 11(9):1004-16. PubMed ID: 23754844
[TBL] [Abstract][Full Text] [Related]
16. [The expression of CXCR4 on acute leukemia cells and its implication for extramedullary infiltration].
Li S; Chen ZX; Wang W; Chen JN; Fu JX; Yao L
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):405-8. PubMed ID: 15355692
[TBL] [Abstract][Full Text] [Related]
17. Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells.
Prasad A; Qamri Z; Wu J; Ganju RK
J Leukoc Biol; 2007 Sep; 82(3):465-76. PubMed ID: 17565045
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Zap70 and CXCR4 receptor at lamellipodia that determines the directionality during Jurkat T cells chemotaxis.
Wu CY; Tsai YY; Chen SY; Lin YP; Shin JW; Wu CC; Yang BC
Mol Immunol; 2017 Oct; 90():245-254. PubMed ID: 28846922
[TBL] [Abstract][Full Text] [Related]
20. POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL.
Sison EA; Magoon D; Li L; Annesley CE; Romagnoli B; Douglas GJ; Tuffin G; Zimmermann J; Brown P
Oncotarget; 2015 Oct; 6(31):30902-18. PubMed ID: 26360610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
